Post‐publication research integrity concerns in randomized clinical trials: A scoping review of the literature
Authors:
- 3 April 2024
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 166 (3) , 984-993
Abstract
Background: Post‐publication handling of integrity concerns in randomized clinical trials (RCTs) is a contentious matter.Objectives: We undertook a scoping systematic review to map the literature regarding post‐publication integrity issues in RCTs.Search Strategy and Selection Criteria: Following prospective registration (https://osf.io/pgxd8) we initially searched PubMed and Scopus but subsequently extended it to include the Cochrane Library, and Google Scholar databases without language, article type or publication time restriction until November 2022. Reviewers independently selected published articles covering any aspect of post‐publication research integrity concerns in RCTs.Data Collection and Analysis: The study findings grouped within domains relating to issues concerning post‐publication integrity were extracted in duplicate, verified by a third reviewer, and then tabulated.Main Results: The initial search captured 3159 citations, of which 89 studies were included in the review. Cross‐sectional studies constituted the majority of included studies (n = 34, 38.2%), followed by systematic reviews (n = 10, 11.2%), methodology reviews/studies (n = 9, 10.1%) and other types of descriptive studies (n = 8, 9.0%). A total of 21 articles (23.6%) covered the domain on general issues, 25 (28.1%) in the journal's instructions and policies domain, eight (9.0%) in the editorial and peer review domain, one (1.1%) in the correspondence and complaints (post‐publication peer review) domain, 12 (13.5%) in the investigation for concerns domain, six (6.7%) in the post‐investigation decisions and sanctions domain, none in the critical appraisal guidance domain, five (5.6%) in the integrity assessment in systematic reviews domain, and 26 (29.2%) in the recommendations for future research domain. A total of 12 of the selected articles (13.5%) covered two (n = 9) or three (n = 3) different domains.Conclusions: Various research integrity domains and issues covering post‐publication aspects of RCT integrity were captured and gaps were identified, mostly related with the necessary implications for all stakeholders to improve research transparency. There is an urgent need for a multistakeholder consensus towards creating specific statements for addressing post‐publication integrity concerns in RCTs.Keywords
This publication has 105 references indexed in Scilit:
- Letter to the editor: Validity of tests for publication integrityInternational Journal of Gynecology & Obstetrics, 2023
- Integrity of randomized clinical trials: Performance of integrity tests and checklists requires assessmentInternational Journal of Gynecology & Obstetrics, 2023
- Research integrity in randomized clinical trials: A scoping umbrella reviewInternational Journal of Gynecology & Obstetrics, 2023
- Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesisResearch Synthesis Methods, 2022
- When beauty is but skin deep: dealing with problematic studies in systematic reviewsCochrane Database of Systematic Reviews, 2021
- Unsung Heroes of Research IntegrityJournal of Bone and Mineral Research, 2020
- An observation framework for retracted publications in multiple dimensionsScientometrics, 2020
- Reporting and Interpretation of Randomized Clinical TrialsJAMA, 2019
- Publication and Dissemination of Results in Clinical Trials of NeurologyJAMA Neurology, 2018
- The olivieri case: Lessons for AustralasiaJournal of Bioethical Inquiry, 2005